// App-Quantinova.ai

e12536 : Phase II study on radiofrequency ablation in early breast cancer.

Researchers

Presenter

  • Shigeru Imoto

Principal Investigators

  • Takayuki Ueno

  • Hirotsugu Isaka

  • Hiroki Ito

  • Kaisuke Miyamoto

  • Satoshi Morita

Medical Centers

  • Kyorin University School of Medicine, Mitaka-shi, Japan

  • Department of Breast Surgery, Kyorin University, Tokyo, Japan

  • School of Medicine Kyorin University, Mitaka, Japan

  • Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • UMIN000020805

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved